|
 | 银河康乐A(519673)基金投资组合(持股) 年份： | | 截止日期 | 股票代码 | 股票名称 | 数量(万股) | 持有市值(万元) | 占基金资产净值比例(%) | | 2026-03-31 | 300676 | 华大基因 | 32.36 | 1289.55 | 8.39% | | 2026-03-31 | 603520 | 司太立 | 112.71 | 1213.91 | 7.89% | | 2026-03-31 | 002675 | 东诚药业 | 83.82 | 1186.89 | 7.72% | | 2026-03-31 | 300662 | 科锐国际 | 45.15 | 1056.51 | 6.87% | | 2026-03-31 | 300149 | 睿智医药 | 101.61 | 1051.66 | 6.84% | | 2026-03-31 | 688212 | 澳华内镜 | 24.99 | 931.95 | 6.06% | | 2026-03-31 | 300430 | 诚益通 | 50.21 | 875.66 | 5.70% | | 2026-03-31 | 600763 | 通策医疗 | 20.05 | 843.50 | 5.49% | | 2026-03-31 | 600587 | 新华医疗 | 58.09 | 829.00 | 5.39% | | 2026-03-31 | 600976 | 健民集团 | 24.27 | 815.71 | 5.31% | | 2026-03-31 | 301258 | 富士莱 | 25.21 | 800.42 | 5.21% | |
|